Aclarion Announces New Engagement with The London Clinic and London Spine ClinicGlobeNewsWire • Tuesday
Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MDGlobeNewsWire • 05/23/23
Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical CatalystsGlobeNewsWire • 05/19/23
Aclarion skyrockets on positive trial data for lower back pain intelligence platformProactive Investors • 04/24/23
Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician AdvisorGlobeNewsWire • 03/07/23
Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023Accesswire • 02/16/23
Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine SymposiumGlobeNewsWire • 02/15/23
Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon AdvisorGlobeNewsWire • 01/17/23
Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon AdvisorGlobeNewsWire • 12/22/22
Aclarion's Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MDGlobeNewsWire • 12/21/22
Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon AdvisorGlobeNewsWire • 12/19/22
Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator BiomarkerGlobeNewsWire • 12/01/22
Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XVAccesswire • 10/25/22
Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back PainAccesswire • 09/19/22